AFFF Firefighter Foam Lawsuit Updates & News (2026)

Sarah Edwards's profile picture

Sarah Edwards

Contributor

Adam Ramirez, J.D.'s profile picture

Reviewed ByAdam Ramirez, J.D.

Editor

Read in 16mins

Litigation Active – AFFF Cases Are Still Pending

Status: Active – 3M announced a $7.35 billion personal injury settlement on November 3, 2026; claims against other defendants continue

Docket: MDL No. 2873 – In re: Aqueous Film-Forming Foams Products Liability Litigation

Court: U.S. District Court for the District of South Carolina – Judge Richard M. Gergel

Pending cases: 15,270 as of November 2, 2026

Next key date: November 20, 2026 – responses due on challenges to thyroid and liver cancer experts

Article Summary

  • Firefighter lawsuits arise from exposure to the firefighting foam AFFF
  • AFFF contains forever chemicals that cause cancer
  • 3M agreed to a $7.35 billion personal injury settlement

Free AFFF Lawsuit Case Review!

0/2000

Mentioned by

CBSCNNFOXNew York Times

Major Developments in the Lawsuit History

  • November 3, 2026: 3M agreed to settle PFAS personal injury claims for $7.35 billion over nine years ($5.8 billion present value), covering about 99% of current claims.
  • September 28, 2026: Judge Gergel dismissed thousands of claims that lacked required fact sheets or medical records, though most can be reinstated if the records are served within 14 days.
  • August 15, 2025: Judge Gergel canceled the first test trial, set for October 20, 2025, after learning of a large number of unfiled injury claims.
  • March 29, 2024: The court gave final approval to 3M's $10.5 billion to $12.5 billion settlement with U.S. public water suppliers.
  • December 7, 2018: A federal judicial panel sent 75 AFFF cases to Judge Richard M. Gergel in South Carolina, creating MDL No. 2873.
Following the case

Full AFFF Lawsuit Updates Timeline (2018–2026)

58 updates
  1. 3M Agrees to $7.35 Billion Personal Injury Settlement

    3M announced a deal to resolve the PFAS personal injury claims at the center of the AFFF MDL. It will pay $7.35 billion over nine years, worth about $5.8 billion in today's dollars. The company said the deal reaches roughly 99% of current injury claims inside and outside the MDL, with about 115,000 to 120,000 eligible plaintiffs. Claimants must enroll and give a full release. Payments start with $50 million in 2026, with none in 2027, and a $680 million reserve covers remaining and future claims. 3M admitted no liability.

  2. Judge Rules on Objections and Reinstatement Requests

    Judge Gergel overruled objections from 832 plaintiffs who had fought the September dismissal recommendation, so their claims were dismissed without prejudice. Two other objecting groups won because defendants agreed their missing records had since been supplied. In a separate ruling that day, the judge granted most motions to reinstate dismissed plaintiffs, except three named plaintiffs, and turned down one request as untimely.

  3. New Jersey Asks to Drop Its AFFF Case Under Consent Orders

    The State of New Jersey and its Department of Environmental Protection moved to voluntarily dismiss their AFFF action in the MDL, Case No. 2:19-cv-02199. The filing relies on Rule 41(a)(2), which needs the court's approval, and describes the request as consistent with judicial consent orders, meaning settlement terms entered by a court. Responses were due by November 17, 2026.

Show 55 earlier updates
  1. Special Master Recommends Another Round of Dismissals

    Special master Margaret Seymour issued a second report on a third defense motion under CMO 37. It covered about 461 plaintiffs who had not given medical records backing their claims, plus one who had not served a profile form. She advised dismissal without prejudice. Any of them could return by serving the missing form or records showing the injury within 14 days of a final dismissal order. Objections were due October 27, 2026.

  2. Duplicate Case Problems Under CMO 38 Resolved

    CMO 38 had required each injured plaintiff to keep just one pending case covering the whole claim. Special master John W. Perry, Jr. told the court that every multiple-filing and representation issue flagged when that order was entered had been cleared up.

  3. California Loses Bid to Halt Corteva Split

    California asked the court to block Corteva from splitting in two, with its seed business spun off as Vylor, Inc. The state argued the move continued a DuPont-related plan to shift assets beyond creditors' reach. After the Fourth Circuit summarily reversed an earlier refusal to let California file the motion, Judge Gergel denied it on the merits the same day. He found the state had known of the deal since December 2025 yet filed only 17 days before closing, and that it could seek the same relief from the new companies. California appealed again on October 2.

  4. Thousands of Claims Missing Required Records Dismissed

    On September 3, 2026, the special master recommended dismissing 25 claims with prejudice, so they cannot be refiled, and about 13,226 more without prejudice. Those 13,226 plaintiffs could be reinstated if they served completed fact sheets and any required medical records within 14 days of a final dismissal order. Judge Gergel adopted the recommendation on September 28, except for plaintiffs who had filed timely objections.

  5. Expert Challenge Schedule for Thyroid and Liver Cancer Reset

    Judge Gergel adopted a new briefing plan for Rule 702 motions, which ask the court to bar expert witnesses whose science may be unreliable. The motions target general causation experts on thyroid cancer and liver cancer. Under CMO 33F, the motions were due by August 26, 2026, responses by November 20, 2026, and replies by January 22, 2027. The court said it would later advise on any hearing.

  6. Panel Creates Separate MDL for Turnout Gear-Only Claims

    The federal panel that assigns MDLs declined to fold turnout gear purchaser class actions into the AFFF MDL. It instead created MDL No. 3191 in the District of Minnesota before Judge Jeffrey M. Bryan, renamed for non-AFFF turnout gear claims. The Panel said cases raising both AFFF and turnout gear claims would still go to the AFFF MDL, and the two judges could coordinate overlapping discovery.

  7. Group B Bellwether Deadlines Pushed to November 2026

    In March 2026, the court had declared Tier 2 discovery in the Group B bellwether cases largely complete. A new order, CMO 26O, moved the parties' next deadline from July 20 to November 20, 2026. By then, they must propose which of three ulcerative colitis plaintiffs moves into expert discovery and a plan for that phase. Thyroid disease plaintiffs John Slagle and Karin Frazier and colitis plaintiff James Zajicek were already set to advance.

  8. Special Master Named to Review Mass Dismissal Motions

    Defendants had filed a wave of motions to dismiss plaintiffs who missed record rules under CMOs 5, 35, and 37, and the court expected them to soon pass 8,000. With no objections from either side, Judge Gergel appointed retired judge Margaret Seymour as special master. She was to review these motions and recommend rulings, with a goal of 90 days or less. Either side could object to her reports within 21 days.

  9. Court Orders Plaintiffs With Duplicate Filings to Keep One Case

    Some injured people had filed more than one personal injury case, often through different law firms. In CMO 38, the judge ruled that each plaintiff may keep only one active case. The court's portal administrator was told to flag duplicates. Lawyers then had 30 days to confer on which case stays and who represents the client, and 60 days to dismiss the extra filings.

  10. Process Set to Dismiss Plaintiffs Missing Required Records

    Many plaintiffs had not submitted fact sheets, profile forms, or medical records the court requires. CMO 37 lets defendants serve lists of non-compliant plaintiffs. Those named get 14 days to fix the gaps through the court's online portal, or 90 days if only a signed verification is missing. After that, defendants may ask the court to dismiss, and plaintiffs get 14 days to respond.

  11. Thyroid and Liver Cancer Expert Depositions Scheduled

    Both sides had traded general causation expert reports on thyroid cancer and liver cancer. CMO 33C set expert depositions to start no earlier than February 9, 2026 and finish by April 17, 2026. Plaintiffs' experts would be questioned before the matching defense experts. The order also set a first schedule for motions to exclude experts, which later orders pushed back.

  12. Government Shutdown Delays Group B Discovery

    Discovery in the Group B bellwether cases slowed because the government shutdown held up records from the U.S. Air Force. In CMO 26M, the court extended Tier 2 discovery for these plaintiffs to March 19, 2026. The parties were to pick which ulcerative colitis plaintiff would join the thyroid disease cases in expert work by that same date.

  13. Panel Refuses to Add Turnout Gear-Only Cases to AFFF MDL

    3M asked the Judicial Panel to move four lawsuits from Virginia and Missouri into the AFFF MDL. Those plaintiffs claimed harm from PFAS in firefighter protective gear, not from foam. The Panel denied the transfers, stressing that the MDL was built for harm tied to AFFF and that adding gear-only claims would turn it into a general PFAS case.

  14. Three Ulcerative Colitis Plaintiffs Advance to Tier 2

    Both sides jointly proposed three more ulcerative colitis plaintiffs for deeper discovery: Tracy Gutierrez, Mary Shuman, and Sylvia Smith. The court approved all three for Tier 2 discovery. Only one would later move into expert discovery, alongside James Zajicek, a colitis plaintiff chosen in 2024.

  15. Judge Targets Efforts to Plead Around the AFFF MDL

    Some PFAS injury plaintiffs dropped or denied any AFFF exposure in their complaints to keep their cases out of federal court. In CMO 36, Judge Gergel called this artful pleading and found a plausible basis for federal jurisdiction in such cases. He asked the Judicial Panel to send all of them, including firefighter turnout gear cases, to his court.

  16. First Bellwether Trial Vacated; 21-Day Filing Window Opened

    After learning of a large number of unfiled injury claims, Judge Gergel vacated the trial set for October 20, 2025. CMO 35 gave lawyers 21 days to file claims for six listed injuries: kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, liver cancer, and thyroid cancer. Complaints could bundle up to 150 plaintiffs. Cases filed later must serve full medical records within 90 days and expert reports on causation within 120 days.

  17. Leadership Teams Reappointed Through May 2026

    The court renewed the lawyer leadership for both sides for the May 2025 to May 2026 term. Under CMO 34, Michael A. London, Scott Summy, and Joseph F. Rice stayed on as plaintiffs' co-leads, with Fred Thompson III as liaison counsel. Each appointment lasts one year, and lawyers must reapply to keep serving.

  18. Judge Calls Conference Over Unfiled Claims Before Mediation

    Defense leaders told the court that plaintiffs' lawyers had revealed thousands of unfiled injury claims tied to the six diseases being pursued. Judge Gergel said a sudden buildup of unfiled claims could disrupt the MDL and hurt ongoing settlement talks. He set a phone conference for July 22, 2025, asked mediator Layn Phillips to join, and told plaintiffs' co-leads to report claim counts by July 18. The parties' next mediation session was set for July 25, 2025.

  19. Court Holds Science Day on Thyroid and Liver Cancer

    Judge Gergel held an educational Science Day where both sides presented experts on whether PFAS exposure from AFFF can cause thyroid cancer and liver cancer. A later order confirms the session took place on this date. Formal expert reports and challenges on these two cancers followed in the months after.

  20. Pretrial Schedule Set for First Kidney Cancer Trial

    The court issued CMO 26I, the pretrial plan for the first bellwether trial. Motions in limine, which ask the judge to allow or block evidence before trial, were due by September 5, 2025. Jury questionnaire drafts were due in August. The chosen case or cases were subject to being called for trial on October 20, 2025.

  21. First Trial Narrowed to Three Kidney Cancer Plaintiffs

    The court decided the first personal injury trial would involve one or more of three kidney cancer plaintiffs, as 3M later reported. The cases were Donnelly, Speers, and Voelker. A later scheduling order notes the judge reserved his choice of which case would go first.

  22. Three More Ulcerative Colitis Cases Added to Discovery Pool

    On March 14, 2025, both sides jointly proposed three more plaintiffs with ulcerative colitis for early discovery. The court approved them on this date, according to CMO 26H. That order set their Tier 1 discovery to run from April 7 to August 11, 2025.

  23. Thyroid and Liver Cancer Track Gets Expert Schedule

    Judge Gergel issued CMO 33, setting deadlines for expert reports, expert discovery, and challenges to experts on thyroid cancer and liver cancer. The order also moved the Science Day on these two cancers from June 6, 2025 to June 20, 2025.

  24. Product Identification Plan Set for Property Damage Sites

    Owners of airports, fire training centers, and similar sites claim AFFF used on their land caused contamination. CMO 32 created a process to choose a set of these sites for focused discovery into whose foam was actually used there. Only sites where AFFF was allegedly used on the property itself could qualify.

  25. First Bellwether Trial Moved to October 20, 2025

    The parties jointly asked for more time to finish expert discovery in the Group A kidney and testicular cancer cases. The court granted part of the request and, in CMO 26G, moved the first trial date from October 6 to October 20, 2025.

  26. Court Orders More Ulcerative Colitis Cases for Group B

    Group B then held two thyroid disease plaintiffs and one ulcerative colitis plaintiff. Because the court wanted enough colitis cases, CMO 26F told the parties to propose two to four more colitis plaintiffs for early discovery. It also reset the schedule for Group B fact discovery.

  27. Plaintiffs' Co-Lead Counsel Resigns

    Paul J. Napoli stepped down as one of the plaintiffs' co-lead lawyers, and the court accepted his resignation. Michael A. London, Scott Summy, and Joseph Rice kept their co-lead roles. The judge added Hunter J. Shkolnik to the Plaintiffs' Executive Committee.

  28. Carrier Reaches Deal Over Kidde-Fenwal AFFF Claims

    Carrier Global signed a settlement and plan support agreement with its bankrupt former unit Kidde-Fenwal, the creditors' committee, and the MDL plaintiff co-leads. Carrier's annual report says it would pay $615 million in cash over five years. It would also hand over net proceeds from selling Kidde-Fenwal's assets, estimated at $115 million, plus certain insurance rights.

  29. Plaintiff Profile Form Required for Injury Claims

    To get a clearer picture of the injury claims, the court adopted a Plaintiff Profile Form in CMO 31. It adds to the existing fact sheet and must be filed through an online portal. Deadlines run from 60 to 150 days depending on how many clients a law firm has. People claiming only turnout gear exposure use a separate fact sheet instead.

  30. First Personal Injury Trial Scheduled for October 6, 2025

    In CMO 26E, the court set deadlines for expert reports, expert discovery, and summary judgment in the Group A cases. It set the first Group A trial date for October 6, 2025. Fact discovery for Group A ran until December 16, 2024.

  31. Judge Picks Bellwether Trial Pool Cases

    The court picked the plaintiffs for the bellwether trial pool, a set of test cases prepared for possible trial. 3M's quarterly filing says nine cases were chosen for more discovery, including expert work. A later scheduling order dates the selection to this day.

  32. Bellwether Pool Split Into Group A and Group B

    The bellwether pool then held 25 plaintiffs exposed through drinking water near two sites. CMO 26D split the trial pool into two groups on staggered schedules. Group A would hold three kidney cancer and three testicular cancer plaintiffs. Group B would hold two ulcerative colitis and three thyroid disease plaintiffs.

  33. Tyco Agrees to $750 Million Water System Settlement

    Tyco Fire Products, a Johnson Controls unit, agreed to pay $750 million to a nationwide class of public water systems over PFAS claims tied to its foam. The deal also releases claims against Chemguard. Johnson Controls later reported that Tyco paid the full amount, with the final $415 million paid in December 2024.

  34. Court Gives Final Approval to 3M Water Settlement

    The federal court in Charleston granted final approval to 3M's class settlement with U.S. public water suppliers. 3M will pay between $10.5 billion and $12.5 billion, with payments scheduled through 2036. Per 3M's later filing, the deal took effect in May 2024.

  35. Process Set for Diseases Outside the First Bellwethers

    CMO 28 told plaintiffs to list other diseases they link to AFFF and set an exchange of published studies before a Science Day. Plaintiffs with unlisted diseases could drop those claims without prejudice, meaning they could refile later. A later version set August 22, 2024 as the deadline and kept a tolling period of up to four years.

  36. Turnout Gear Plaintiffs Get Their Own Fact Sheet

    Some plaintiffs blame PFAS in firefighter turnout gear for their illness. The court approved a gear-specific Plaintiff Fact Sheet in CMO 5F for anyone suing a turnout gear maker. These plaintiffs must still complete the standard personal injury fact sheet.

  37. DuPont, Chemours, and Corteva Water Deal Approved

    The court granted final approval to the $1.185 billion public water system settlement with Chemours, DuPont, and Corteva. A final judgment followed on February 26, 2024. One water system appealed, but that appeal was dismissed in April 2024.

  38. Court Confirms First 25 Personal Injury Bellwether Plaintiffs

    The court confirmed the parties' picks for the first discovery pool of injury test cases, which held 25 plaintiffs. These cases then entered 24 weeks of core discovery, with set limits on depositions. Under an earlier order, all parties in each picked case had to waive Lexecon rights, allowing trial in South Carolina rather than the original court.

  39. Two Telomer Water Cases Chosen for Deeper Discovery

    For the telomer foam bellwether track, the judge selected two water provider cases for Tier Two discovery. They were City of Watertown v. 3M Company and Southeast Morris County Municipal Utilities Authority v. 3M Company.

  40. New Bellwether Program Launched for Telomer Foam

    With water claims against 3M, Chemours, DuPont, and Corteva headed for settlement, CMO 27 started a separate water provider bellwether track for cases involving telomer-based AFFF. The order also noted that the Delaware bankruptcy court had paused AFFF claims against Kidde-Fenwal affiliates and National Foam.

  41. 3M Settles Public Water System Claims

    3M entered a class settlement to resolve PFAS drinking water claims by U.S. public water systems, subject to court approval. It expected to book a pre-tax charge of about $10.3 billion. The City of Stuart case, picked as the first bellwether trial, was also settled as part of this deal.

  42. Chemours, DuPont, and Corteva Agree to $1.185 Billion Deal

    The three companies signed a binding agreement in principle to resolve PFAS drinking water claims of a defined class of U.S. public water systems in the AFFF MDL. They agreed to fund a $1.185 billion settlement. Chemours pays half, about $592 million, and DuPont and Corteva together cover the other half.

  43. Kidde-Fenwal Files for Chapter 11 Bankruptcy

    Kidde-Fenwal, a Carrier subsidiary whose former National Foam business made AFFF, filed for Chapter 11 in Delaware. All litigation against it was automatically paused. By agreement, AFFF suits against Carrier, its other subsidiaries, and RTX were also stayed.

  44. Personal Injury Bellwether Program Begins

    CMO 26 launched the first bellwether program for injury claims. Eligible plaintiffs had to allege drinking water exposure near Peterson Air Force Base or the Willow Grove and Warminster naval sites. The parties were to choose 28 plaintiffs: eight each for kidney cancer, testicular cancer, and thyroid disease, plus four with ulcerative colitis.

  45. Court Appoints Mediator for Settlement Talks

    The judge named retired judge Layn Phillips as a court-appointed mediator to help the parties negotiate. The same order gave the plaintiffs' and defendants' co-lead counsel sole authority to pursue settlements. Any party wanting to negotiate on its own first needed approval from its co-leads.

  46. City of Stuart Trial Set for June 5, 2023

    The court reset the schedule for the first water provider bellwether, the City of Stuart's case against 3M and others. Under CMO 19F, summary judgment and expert motions were due by December 2, 2022. The case was set to be called for jury selection or trial on June 5, 2023.

  47. Government Contractor Defense Rejected at Summary Judgment

    Defendants argued the government contractor defense shields them for foam sold to or used by the U.S. government. After briefing and argument, the court declined to grant MDL-wide summary judgment on this defense. Defendants may still raise it before juries at trial, 3M noted.

  48. Schedule Set for First Water Provider Trial

    CMO 19 laid out the road to the first bellwether trial for public water provider cases. Tier Two discovery was to end by January 21, 2022, followed by expert reports, depositions, and summary judgment briefs. The chosen case could be called for trial on or after January 1, 2023.

  49. Tyco Settles Peshtigo Residents' Case for Up to $17.5 Million

    Tyco and residents of the Town of Peshtigo, Wisconsin agreed to settle a lawsuit that had been moved into the MDL, Johnson Controls reported. Tyco would pay up to $17.5 million to residents living near its Fire Technology Center in Marinette for property value, exposure, and injury claims. The deal needed court approval.

  50. Court Sets Up First Bellwether Process

    In CMO 13, Judge Gergel created a two-tier bellwether system. Different kinds of claims would get separate test case tracks. Water provider lawsuits were chosen as the first group to be worked up for trial.

  51. Fact Sheets Required From Plaintiffs and Defendants

    The court issued CMO 5, which set the form and use of Plaintiff Fact Sheets and Defendant Fact Sheets, as noted on the court's MDL page. These questionnaires give each side basic facts about every claim early in the case.

  52. Discovery Stay Lifted

    In CMO 4, the court ended the earlier pause on all discovery in the MDL. Exchange of documents could now begin under a set collection protocol and a protective order for confidential material.

  53. Leadership Teams Appointed

    CMO 2 named the lawyers who lead each side, according to the court's MDL page. Michael A. London, Paul J. Napoli, and Scott Summy became plaintiffs' co-leads, with Fred Thompson III as liaison. Joseph G. Petrosinelli and Michael A. Olsen became the defense co-leads.

  54. First Case Management Order Issued

    Judge Gergel's first order merged all transferred actions for pretrial purposes and set filing rules for the MDL, per the court's MDL page. It also scheduled the first status conference for February 25, 2019.

  55. AFFF Lawsuits Centralized in South Carolina

    A federal panel of judges, the JPML, ordered 75 cases claiming AFFF polluted groundwater near airports and other sites sent to the District of South Carolina. They went to Judge Richard M. Gergel as MDL No. 2873. The Panel refused to add nine 3M cases that did not involve AFFF.

Do I Qualify for

AFFF Lawsuit Compensation?
Free Case Review→

AFFF Lawsuit Updates and News, November 2026

As of November 2026, the AFFF MDL has 15,270 cases pending. On November 3, 2026, 3M agreed to a $7.35 billion settlement. The settlement will be paid over nine years, and it should cover about 99% of PFAS personal injury claims.

Most claims against 3M were resolved with that settlement agreement, but claims against other defendants continue.

The court has advanced Group B bellwether cases that involve ulcerative colitis and thyroid disease. It declared Tier 2 discovery in these cases largely complete in March 2026. At this point, two thyroid disease plaintiffs and one ulcerative colitis plaintiff were set to move into expert discovery.

The court set the next deadline for November 20, 2026. By this date, the parties were required to select another ulcerative colitis plaintiff (out of three possible candidates) to join them.

3M Pays New Jersey $400-$450 Millions

On May 12, 2025, 3M agreed to pay the state of New Jersey between $400 million and $450 million over the next 25 years to resolve PFAS contamination claims. This settlement would resolve 3M’s liability in the state’s lawsuits regarding the Chambers Works site (located in Pennsville and Carneys Point) and Parlin site (located in Sayreville), and the DEP’s Statewide PFAS Directive, all initiated in 2019.

In a separate action, New Jersey and its Department of Environmental Protection filed a motion to voluntarily dismiss their AFFF case in the MDL. They filed the motion on November 3, 2026, and they described it as being consistent with judicial consent orders.

It’s not only New Jersey taking action. States across the country are ramping up their fight against PFAS contamination, with legislative efforts and lawsuits gaining momentum. In 2025 alone, at least 37 states introduced PFAS-related bills, signaling a widespread push for stronger regulations.

Bellwether Trials Initially Expected in October 2025

In October 2024, the court handling the AFFF MDL scheduled the first bellwether trial for October 6, 2025. It later moved the trial’s start date to October 20, 2025. However, Judge Gergel vacated the trial on August 15, 2025.

Over the summer and fall of 2025, the parties continued discovery to gather evidence, including expert opinions, to prove links between the health conditions allegedly caused by AFFF exposure.

The court held a Science Day on June 20, 2025. On this day, both sides presented scientific evidence on AFFF and cancer. The presentations were primarily focused on thyroid and liver cancers. Plaintiffs are pursuing claims for the following six conditions:

  • Kidney cancer
  • Testicular cancer
  • Ulcerative colitis
  • Thyroid disease
  • Thyroid cancer
  • Liver cancer

The canceled first bellwether trial was set to include plaintiffs who developed kidney cancer after AFFF exposure. The goal was to test evidence linking kidney cancer to the PFAS present in AFFF.

The trial’s cancellation wasn’t due to the strength of the evidence (or lack thereof). Instead, lawyers for the plaintiffs revealed thousands of injury claims that had not yet been filed. Judge Gergel was concerned that the sudden influx of new claims could be harmful to settlement talks. There was also a possibility that some plaintiffs rushed the filing process to meet the statute of limitations and submitted incomplete paperwork as a result.

Now, the litigation is primarily focusing on challenges to causation experts on liver and thyroid cancers. Under Case Management Order No. 33F (CMO 33F), related motions were due by August 26, 2026. Responses to those motions were due by November 20, 2026, and replies to those responses must be submitted by January 22, 2027.

Judge Gergel Appoints Special Master

On June 15, 2026, Judge Gergel appointed Margaret Seymour, a retired judge, as special master of the MDL. Seymour was tasked with reviewing defense motions to dismiss plaintiffs who missed the court’s records rules. She recommended rulings on each one, and either side had the right to object within 21 days.

However, 13,226 of these claims were dismissed without prejudice, meaning they could be reinstated if missing records were served to the court within 14 days. On November 3, 2026, Judge Gergel reinstated most dismissed plaintiffs, although he overruled the objections of 832 plaintiffs and dismissed their cases.

New AFFF Lawsuits Filed in New York, Arizona and Ohio

In late January 2025, a retired New York firefighter filed an AFFF lawsuit. He worked for the New York Fire Department for over 30 years and later developed thyroid disease. During his firefighting career, the plaintiff was frequently exposed to PFAS in his protective gear and firefighting foam. He is suing for numerous damages, including pain, medical bills and reduced quality of life.

In another AFFF lawsuit, a firefighter from Flagstaff, Arizona, and his wife are seeking damages for severe injuries due to prolonged exposure to PFAS chemicals in AFFF. The firefighter regularly used AFFF during his active career, starting with training. After more than a decade of handling AFFF, he was diagnosed with testicular cancer, requiring surgery and chemotherapy.

A firefighter with non-Hodgkin’s lymphoma from Columbus, Ohio, filed a lawsuit against multiple AFFF and equipment manufacturers. In the lawsuit, he alleges severe injuries from exposure to firefighting foam and gear over a career lasting nearly three decades. The suit is part of the MDL class action and claims manufacturers knew about PFAS’s dangers but failed to warn users or offer safer alternatives.

Now, claims tied to PFAS in turnout gear and not foam are following a separate legal track. In August 2026, MDL No. 3191 was created for non-AFFF turnout gear claims. It’s based in the District of Minnesota before Judge Jeffrey M. Bryan. Cases that involve both AFFF and turnout gear claims still go to the AFFF MDL.

New Scientific Studies Showing PFAS Toxicity

Several studies highlight the serious health risks associated with AFFF and PFAS exposure, reinforcing concerns about their long-term effects.

Study Shows PFAS Neurotoxic Impacts

In a study published in December 2024, researchers from the University at Buffalo identified that 11 important genes that are crucial for brain health were impacted by PFAS exposure. In one instance, PFAS caused less activity in a gene that helps brain cells survive, while another gene that causes brain cells to die was more active when exposed to PFAS.

Researchers found that different PFAS chemicals affect many human genes differently. This means each type of PFAS can uniquely impact our cells because they have different shapes and sizes. They also discovered that the amount of PFAS in a cell doesn't necessarily change how much it affects the genes. So, the toxic effects of PFAS might be similar whether someone is exposed to a little or a lot of the substance.

Scientific Study Links PFAS to Liver Cancer

A study published in JHEP Reports found a strong link between PFAS exposure and liver cancer. It found that individuals with high levels of PFOS (a type of PFAS) in their blood were 4.5 times more likely to develop non-viral hepatocellular carcinoma, a common form of liver cancer.

PFAS and Ulcerative Colitis

A scientific study has uncovered a link between PFAS exposure and ulcerative colitis, adding to the growing body of evidence on the health risks posed by these chemicals. Researchers found that individuals with high levels of PFAS in their bloodstream showed an increased risk of developing ulcerative colitis, a chronic inflammatory bowel disease.

Do I Qualify for

AFFF Lawsuit Compensation?
Free Case Review→

U.S. Government Files Motion to Be Dismissed as AFFF Defendant

In early 2025, the U.S. government filed a motion to be dismissed as a defendant in the MDL federal lawsuit. Judge Gergel, who is assigned to this case, had scheduled a hearing on this matter, which took place on February 7, 2025. While the outcome of the hearing is still unclear as of March 2025, legal experts believe it is unlikely that the government will be dismissed from the case.

EPA Wants to Hold PFAS Manufacturers Accountable

In 2025, EPA Administrator Lee Zeldin announced a plan to clean up PFAS and make polluters pay for the damage they’ve caused. The EPA will now limit how much of these harmful chemicals companies can release into water, especially targeting firefighting foam makers and metal finishing businesses.

The agency is also working with Congress to create new rules that force companies that caused the pollution to pay to clean it up, instead of leaving taxpayers to foot the bill. The plan includes more testing, stricter rules about handling chemical waste, and tougher penalties for companies that break the rules.

Department of War Identifies Contaminated Sites

As of June 30, 2026, the Department of War (DoW), formerly the Department of Defense, has identified 727 military installations that need assessment for PFAS use or potential release. Of these, 590 are moving to the next phase of cleanup. PFAS have seeped into groundwater, soil and drinking water around many of these bases, raising health concerns for military members and nearby communities.

Do I Qualify for

AFFF Lawsuit Compensation?
Free Case Review→

3M Settles AFFF Personal Injury Claims

On November 3, 2026, 3M reached a settlement agreement for existing PFAS claims. The company agreed to pay $7.35 billion over nine years, and it says that approximately 115,000 to 120,000 plaintiffs are eligible.

To receive a portion of the settlement, plaintiffs must enroll and release 3M from future liability. 3M is setting aside a $680 million reserve fund to cover remaining PFAS claims and claims that may be filed in the future.

Trump Overturns PFAS Ban

In late January 2025, the Trump administration withdrew a proposed ban on per- and polyfluoroalkyl substances (PFAS) in drinking water. The Environmental Protection Agency (EPA) has been working on a plan to limit PFAS in drinking water and industrial wastewater to protect public health from the harmful effects of these persistent chemicals.

Overturning the PFAS ban could create challenges for plaintiffs filing lawsuits, such as increasing their burden of proof to demonstrate that AFFF caused their health problems. It could also potentially be harder for plaintiffs to argue that manufacturers violated safety standards, which may weaken their cases and make it challenging to secure favorable verdicts or settlements.

Firefighters and safety groups across the United States are raising the alarm about Aqueous Film-Forming Foam (AFFF)—for good reason. This substance contains toxic, life-altering “forever chemicals” that remain in the body indefinitely. According to the Environmental Working Group, forever chemicals cause cancers, birth defects and other severe ailments.

Manufacturers and federal agencies—including the Department of Defense—were aware of these dangers for decades but did nothing to protect firefighters. Regulators fueled the flames by continuing to approve AFFF for nationwide firefighting operations.

Firefighters and grieving loved ones who lost someone to AFFF exposure can take legal action. ConsumerShield can help you begin this process. Complete our online form to start your claim.

Do I Qualify for

AFFF Lawsuit Compensation?
Free Case Review→

Media Reports 3M Knew About AFFF Toxicity

Early in 2025, The Guardian revealed that 3M, the manufacturer of firefighting foams containing PFAS chemicals, knew about the environmental and health risks of these “forever chemicals” for decades. Internal documents dating back to the 1940s showed that 3M knew that PFAS chemicals were not biodegradable and persist in the environment.

Despite this knowledge, 3M continued to market its firefighting foams as safe and biodegradable well into the 1990s. The company only phased out the production of these harmful chemicals in recent years, but the environmental and health impacts of PFAS continue to be a major concern.

What Is Aqueous Film-Forming Foam (AFFF)?

AFFF is a fire suppressant used primarily to extinguish petroleum-based fires in military, aviation and industrial settings. It spreads a thin aqueous film that rapidly cuts off the oxygen supply, suffocating the fire and preventing reignition by creating a cooling barrier. AFFF is particularly useful for large-scale fire emergencies, such as airport fires or in a military context, where fires must be rapidly extinguished to avoid fatalities and extensive damage.

Though extremely effective, AFFF has come under scrutiny. Researchers continue to uncover significant health risks and environmental concerns stemming from its chemical composition. AFFF contains per- and poly-fluoroalkyl substances, commonly known as PFAS. As a result, many of the industries dependent on AFFF and regulatory bodies are now seeking alternatives to the firefighting foam.

Why AFFF Is Considered Dangerous

The use of AFFF poses significant health and environmental risks. PFAS includes more than 9,000 synthetic chemicals used in consumer and industrial products worldwide. Dubbed “forever chemicals,” PFAS don’t break down easily and can accumulate over time in the environment and the human body.

Forever chemicals are linked to poor health outcomes, including cancer, increased cholesterol levels and immune system effects. Apart from long-term detrimental health effects, exposure to PFAS can also cause immediate symptoms, including headaches and dizziness, respiratory distress and eye and skin irritation. Additionally, PFAS contamination can seep into groundwater and soil, threatening entire communities.

If you were exposed to AFFF, whether during your military service or elsewhere and developed a disease linked to AFFF or PFAS, you could qualify for an AFFF settlement. Fill in our form for a free case review today to clarify your rights and the next best steps.

Do I Qualify for

AFFF Lawsuit Compensation?
Free Case Review→

Health Risks Associated With AFFF

PFAS, which makes up part of AFFF, is known to have detrimental impacts on the health of those exposed to firefighting foam. Here are some significant health risks linked to PFAS:

  • Cancer: Exposure to PFAS chemicals in AFFF is linked to a variety of cancers, such as kidney, testicular cancer and breast cancer
  • Hormonal Disruption: PFAS are known endocrine disruptors. They have been linked to hormonal imbalances that may have a detrimental effect on fertility, increase the risk of thyroid problems and have other harmful health impacts.
  • Immune System Dysfunction: PFAS compounds can weaken the immune system, potentially reducing the body’s ability to fight infections. A compromised immune system also reduces the efficacy of childhood vaccinations.
  • Birth Defects and Developmental Issues: Prenatal exposure to PFAS has been linked to low birth weight, high blood pressure in expecting mothers, pre-eclampsia and developmental delays in children.
  • Liver Damage: Long-term exposure to AFFF chemicals can cause changes in liver enzymes, resulting in conditions such as a non-alcoholic fatty liver.

In addition to the listed diseases, PFAS can cause other negative health effects. If you were exposed to AFFF and developed an illness or concerning symptoms, visit a doctor promptly for diagnosis and treatment.

What Is the AFFF Lawsuit?

AFFF lawsuits are currently part of a multidistrict litigation (MDL). Unlike a class action lawsuit, an MDL involves several individual lawsuits rather than a large one representing a group of plaintiffs. The court treats the claims separately but manages them under the same procedures to promote efficiency.

The MDL began in December 2018. A federal panel sent 75 AFFF cases to Judge Richard M. Gergel in the District of South Carolina. The case became known as MDL No. 2873. As of November 2026, there were 15,270 cases pending in the AFFF litigation.

These cases indicate that firefighters developed cancer due to AFFF exposure, mainly during field accidents, industrial fires, jet fuel fires and military operations. Plaintiffs include the firefighters and surviving loved ones of firefighters who died of their cancers.

Science backs these claims solidly. Occupational Medicine published a study showing firefighters are 60% more likely to die of cancer than the general population. Prostate cancer deaths were four times higher, leukemia was three times higher and kidney cancer deaths were twice the rate of those in the general population. The study indicated chemical exposure, including AFFF, contributed to these outcomes.

The lawsuits seek damages arising from these illnesses. Damages include medical costs, pain and suffering, lost wages, lost earning potential and loss of support or companionship (in wrongful death cases). Class action and MDL lawsuits base damage awards on a tier system.

AFFF Statute of Limitations

A statute of limitations is a time limit from the date of injury to when you can file a lawsuit. Depending on state law, statutes of limitations in chemical exposure claims range from two to four years. Filing an AFFF lawsuit before your state’s deadline is crucial as filing too late could prevent you from recovering compensation.

However, the clock generally only starts ticking on the date you became aware of your illness–not the moment of exposure. For example, you may be retired from firefighting for 10 years, but if you receive a cancer diagnosis, that’s the date your statute of limitations starts counting down.

So if your doctor informed you of a cancer diagnosis on August 1, 2025, and your state has a three-year statute of limitations, you have until August 1, 2028, to file.

It is often worth speaking to a lawyer, even if you feel it is too late. Claims involving medical diagnoses are often flexible under some state laws, or there are circumstances you may not know can help your case. Consultations are free, so there is nothing to lose by seeing if you qualify for compensation.

AFFF Manufacturer Defendants

The most common defendants in these lawsuits are AFFF manufacturers. Named defendants so far include:

  • Tyco Fire Products
  • 3M Company
  • Dupont
  • Kidde Fire Fighting
  • Chemguard
  • Chemours Company
  • Buckeye Fire Equipment
  • BASF Corp.
  • Arkema, Inc.

This list of manufacturer defendants is not exhaustive, and there may be other corporations involved in AFFF compensation claims. Investigations have revealed that some of these manufacturers knew of AFFF’s health risks, yet they continued to market and distribute this product to fire departments across the nation.

Do I Qualify for

AFFF Lawsuit Compensation?
Free Case Review→

Settlement Amounts and Projections

No two AFFF lawsuits are the same, and settlement amounts can vary significantly depending on factors like the extent of your illness or injury due to AFFF exposure, your medical expenses and other losses, and the extent of your exposure to the harmful substance. While no universal AFFF settlement amount exists, individuals with severe health impacts due to PFAS exposure have recovered five- and six-figure settlements.

Defendants in AFFF lawsuits have already agreed to pay billions. 3M has already agreed to pay $7.35 billion for personal injury claims. Multiple defendants have agreed to pay even larger settlements for public water system cases:

  • 3M: $10.5 billion to $12.5 billion
  • Chemours, DuPont and Corteva: $1.185 billion
  • Tyco: $750 million

While no amount of compensation can turn back the time and restore your health, a fair settlement allows you to hold the responsible party accountable and recover financial relief. If you or a family member is affected, seek legal advice promptly to clarify your rights and pursue the compensation you deserve.

AFFF Use in Navy Firefighting

Navy firefighters are also filing cancer claims. Firefighting foam is highly effective on aircraft carriers, making it a staple when fires arise.

This practice has been in effect for more than 50 years. In fact, the Department of Defense (now the Department of War) required PFAS to make the foam. Today, the department is investigating PFAS releases at 727 military installations, and it continues to find PFAS in drinking water and groundwater near its sites.

The DOD has since taken action to make water at military installations safer and to discontinue using PFAS products, including firefighter foam. However, the VA faces more AFFF claims, and some victims filed lawsuits.

Do I Qualify for

AFFF Lawsuit Compensation?
Free Case Review→

Were You Exposed to AFFF?

If you are a civilian, military or veteran firefighter who used AFFF and subsequently developed cancer or another serious health condition, you may be eligible to pursue AFFF compensation through a lawsuit. AFFF exposure is linked to toxic PFAS chemicals that can remain in the human body for decades and increase the risk of severe diseases.

ConsumerShield can help you find a lawyer to represent you, so you receive the compensation you deserve. Complete the online form today to get started.

AFFF Lawsuit Knowledge Base

Frequently Asked Questions

  • Aqueous Film-Forming Foam (AFFF) is a type of firefighting foam used to extinguish fuel-based fires. AFFF is dangerous because it contains Per- and Polyfluoroalkyl Substances (PFAS), a class of man-made chemicals known as "forever chemicals." These chemicals are resistant to degradation and can persist in the environment and in human bodies for a long time, leading to various health and environmental risks.

  • Exposure to PFAS chemicals in AFFF has been linked to various types of cancer, including prostate, testicular, kidney and pancreatic cancer. Other health issues associated with PFAS exposure include immune system disorders, hormonal disruption and endocrine-related diseases.

  • The statute of limitations for AFFF lawsuits typically ranges from two to four years, depending on state law, but the clock generally starts ticking from the date you became aware of your illness rather than the moment of exposure.

Resources

Explore related articles and sources cited on this page.

More About AFFF Lawsuit